Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Randomised Controlled Exercise Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 88
- 试验地点
- 2
- 主要终点
- Concentration of circulating Cer16:0, Cer18:0, Cer24:0 and Cer24:1
研究概览
简要总结
The purpose of this study is to assess the effects of an 8-week supervised high-intensity interval training (HIIT) program (vs. physical activity recommendations according to current guidelines) on a comprehensive panel of circulating sphingolipids in middle-aged females and males at elevated cardiometabolic risk.
详细描述
Cardiometabolic diseases (CMD) account for about half of all deaths from non-communicable diseases and are responsible for about one-third of all deaths worldwide. To combat the growing burden of CMD on health systems, a shift towards more effective prevention and early detection of these diseases is urgently needed.
Blood lipids have been used since the middle of the last century to determine the risk of developing CMD. Although classically used biomarkers such as cholesterol and triglycerides provide acceptable risk assessment, there is increasing evidence that sphingolipids, particularly ceramides, may allow improved risk assessment. Mechanistically, there is growing data that sphingolipid accumulations lead to atherosclerosis and insulin resistance.
To measure circulating sphingolipids in clinical practice, it is essential to provide patients with evidence-based interventions that reduce sphingolipid levels and quantify the reduction expected from such an intervention. Preliminary data suggest that regular physical activity (PA), an effective, low-cost, and patient-empowering means of health optimisation, may reduce sphingolipid levels.
The current research project aims to explore whether and to what extent a fitness-enhancing high-intensity interval training (HIIT) programme can lower circulating sphingolipid levels in middle-aged individuals at elevated cardiometabolic risk (50% females). An 'omic-scale sphingolipid profiling will be applied to capture the circulating sphingolipidome comprehensively.
Participants will be randomly allocated to either the intervention or the control group. The exercise intervention will consist of an 8-week supervised HIIT (two walking- and one indoor cycling-based session weekly). The control group will get PA recommendations based on current guidelines.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
盲法说明
As the randomisation will take place after the baseline examination, participants, exercise scientists, and physicians supervising the intervention will be blinded for group allocation at baseline but not post-intervention.
入排标准
- 年龄范围
- 40 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •female or male sex,
- •aged between 40 and 60 years,
- •body mass index between 25.0 and 34.9 kg/m2,
- •sedentary lifestyle, defined as not meeting the WHO guidelines on PA, i.e., at least 150 minutes of moderate-intensity aerobic PA per week as well as muscle-strengthening activities on two or more days per week,
- •medical clearance for HIIT by a study physician (including vital sign evaluation, clinical examination, resting and exercise ECG),
- •informed consent as documented by signature.
排除标准
- •known pregnancy or breastfeeding,
- •any current exercise-limiting musculoskeletal conditions of the lower limbs,
- •any known current or chronic conditions limiting exhaustive exercise,
- •known diabetes mellitus of any type,
- •dyslipidaemia, if pharmaceutically treated,
- •arterial hypertension ≥160/100 mmHg, pharmaceutically treated or not,
- •any other known cardiovascular disease,
- •known NASH,
- •known macular degeneration, glaucoma, or high intraocular pressure (≥20 mm Hg),
- •particular diet (vegetarian, vegan, lactose-free, gluten-free, or FODMAP-low diet (ferment-able oligosaccharides, disaccharides, monosaccharides, and polyols),
- •intake of glucagon-like peptide-1 analogues, orlistat or any weight-loss drug,
- •inability to follow the procedures of the study, e.g., due to linguistic or cognitive problems,
- •concomitant involvement in another interventional trial or participation in another interventional trial in the last four weeks.
结局指标
主要结局
Concentration of circulating Cer16:0, Cer18:0, Cer24:0 and Cer24:1
时间窗: At baseline and after the 8-week intervention
Quantifying the changes in plasma level of the four sphingolipid species included in the ceramide-based scores (Cer16:0, Cer18:0, Cer24:0 and Cer24:1) following the 8-week HIIT programme (vs. physical activity recommendation).
次要结局
- Concentration of the other circulating sphingolipid species to be targeted(At baseline and after the 8-week intervention)
- Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)(At baseline and after the 8-week intervention)
- Retinal microvascular diameters(At baseline and after the 8-week intervention)
- Peak oxygen uptake (VO2peak)(At baseline and after the 8-week intervention)
- Brachial flow-mediated dilatation (FMD)(At baseline and after the 8-week intervention)
研究者
Justin Carrard
Postdoctoral researcher, Principal investigator
University of Basel